Cycloastragenol and Astragaloside IV activate telomerase and protect nucleus pulposus cells against high glucose‑induced senescence and apoptosis

Hong,Haofeng; Xiao,Jian; Guo,Quanquan; Du,Jinhui; Jiang,Zhichen; Lu,Sisi; Zhang,Hongyuan; Zhang,Xiaolei; Wang,Xiangyang

doi:10.3892/etm.2021.10761

Cycloastragenol and Astragaloside IV activate telomerase and protect nucleus pulposus cells against high glucose‑induced senescence and apoptosis

Authors:
- Haofeng Hong
- Jian Xiao
- Quanquan Guo
- Jinhui Du
- Zhichen Jiang
- Sisi Lu
- Hongyuan Zhang
- Xiaolei Zhang
- Xiangyang Wang
View Affiliations

Affiliations: Department of Orthopedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Second Medical School of Wenzhou Medical University, Hangzhou, Zhejiang 310000, P.R. China
Published online on: September 20, 2021 https://doi.org/10.3892/etm.2021.10761
Article Number: 1326
Copyright: © Hong et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

In diabetes‑induced intervertebral disc degeneration (Db‑IVDD), senescence and apoptosis of nucleus pulposus cells (NPCs) are major contributing factors. Telomere attrition and telomerase downregulation are some of the main reasons for senescence and eventual apoptosis. The derivatives of the Chinese herb Astragalus membranaceus, Cycloastragenol (CAG) and Astragaloside IV (AG‑IV), are reportedly effective telomerase activators against telomere shortening; however, their effect in Db‑IVDD have not been explored. The present study simultaneously investigated the regulation of these derivatives on senescence, apoptosis, telomeres and telomerase a model of high‑glucose (HG)‑induced stress using rat primary NPCs. The NPCs were stimulated with HG (50 mM) to evoke HG‑induced stress, and the effects of CAG and AG‑IV were observed on: i) The expression level of senescence marker p16; ii) β‑Gal staining; iii) the expression levels of apoptosis markers cleaved‑caspase 3 (c‑C3), BAX and Bcl‑2; iv) telomerase activation with telomerase reverse transcriptase (TERT) mRNA and protein expression, while telomere length was measured with reverse transcription‑quantitative PCR. Cell proliferation was determined using the Cell Counting Kit‑8 assay. Results demonstrated an upregulation in the expression levels of p16, c‑C3 and BAX, and increased β‑Gal staining; while the expression level of Bcl‑2 was downregulated in a concentration‑dependent manner. Pre‑treatment of the NPCs with CAG and AG‑IV downregulated the protein expression levels of p16, c‑C3 and BAX, and decreased the percentage of β‑Gal and FITC staining; while upregulating the Bcl‑2 expression. These effects protected the cells from HG stress‑induced senescence and apoptosis. HG also downregulated the expression profile of TERT and shortened the telomere length in a glucose concentration‑dependent manner. While pretreatment with CAG and AG‑IV upregulated TERT expression and ameliorated the telomere attrition. CAG and AG‑IV also increased cell proliferation and improved cell morphology in HG conditions. Overall, these findings indicated that CAG and AG‑IV suppressed HG stress‑induced senescence and apoptosis, in addition to enhancing telomerase activation and lengthening of the Telomere. Therefore, CAG and AG‑IV prolonged the replicative capability and longevity of the NPCs and they have the potential to be therapeutic agents in Db‑IVDD.

View Figures

View References

1	Deyo RA and Mirza SK: CLINICAL PRACTICE. Herniated lumbar intervertebral disk. N Engl J Med. 374:1763–1772. 2016.PubMed/NCBI View Article : Google Scholar
2	Modic MT and Ross JS: Lumbar degenerative disk disease. Radiology. 245:43–61. 2007.PubMed/NCBI View Article : Google Scholar
3	Kadow T, Sowa G, Vo N and Kang JD: Molecular basis of intervertebral disc degeneration and herniations: What are the important translational questions. Clin Orthop Relat Res. 473:1903–1912. 2015.PubMed/NCBI View Article : Google Scholar
4	Jiang L, Zhang X, Zheng X, Ru A, Ni X, Wu Y, Tian N, Huang Y, Xue E, Wang X and Xu H: Apoptosis, senescence, and autophagy in rat nucleus pulposus cells: Implications for diabetic intervertebral disc degeneration. J Orthop Res. 31:692–702. 2013.PubMed/NCBI View Article : Google Scholar
5	Wang L, Gao P, Zhang M, Huang Z, Zhang D, Deng Q, Li Y, Zhao Z, Qin X, Jin D, et al: Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013. JAMA. 317:2515–2523. 2017.PubMed/NCBI View Article : Google Scholar
6	Won HY, Park JB, Park EY and Riew KD: Effect of hyperglycemia on apoptosis of notochordal cells and intervertebral disc degeneration in diabetic rats. J Neurosurg Spine. 11:741–748. 2009.PubMed/NCBI View Article : Google Scholar
7	Kong JG, Park JB, Lee D and Park EY: Effect of high glucose on stress-induced senescence of nucleus pulposus cells of adult rats. Asian Spine J. 9:155–161. 2015.PubMed/NCBI View Article : Google Scholar
8	Zhang XU, Yang MK, Li Z, Liu C, Wu JS and Wang J: Expression and significance of telomerase in the nucleus pulposus tissues of degenerative lumbar discs. Biomed Rep. 3:813–817. 2015.PubMed/NCBI View Article : Google Scholar
9	Monickaraj F, Aravind S, Gokulakrishnan K, Sathishkumar C, Prabu P, Prabu D, Mohan V and Balasubramanyam M: Accelerated aging as evidenced by increased telomere shortening and mitochondrial DNA depletion in patients with type 2 diabetes. Mol Cell Biochem. 365:343–350. 2012.PubMed/NCBI View Article : Google Scholar
10	Xiao F, Zheng X, Cui M, Shi G, Chen X, Li R, Song Z, Rudolph KL, Chen B and Ju Z: Telomere dysfunction-related serological markers are associated with type 2 diabetes. Diabetes Care. 34:2273–2278. 2011.PubMed/NCBI View Article : Google Scholar
11	Skvortsov DA, Zvereva ME, Shpanchenko OV and Dontsova OA: Assays for detection of telomerase activity. Acta Naturae. 3:48–68. 2011.PubMed/NCBI
12	Chung SA, Wei AQ, Connor DE, Webb GC, Molloy T, Pajic M and Diwan AD: Nucleus pulposus cellular longevity by telomerase gene therapy. Spine (Phila Pa 1976). 32:1188–1196. 2007.PubMed/NCBI View Article : Google Scholar
13	Eitan E, Tichon A, Gazit A, Gitler D, Slavin S and Priel E: Novel telomerase-increasing compound in mouse brain delays the onset of amyotrophic lateral sclerosis. EMBO Mol Med. 4:313–329. 2012.PubMed/NCBI View Article : Google Scholar
14	Graham MK, Principessa L, Antony L, Meeker AK and Isaacs JT: Low p16(INK4a) expression in early passage human prostate basal epithelial cells enables immortalization by telomerase expression alone. Prostate. 77:374–384. 2017.PubMed/NCBI View Article : Google Scholar
15	Yu Y, Zhou L, Yang Y and Liu Y: Cycloastragenol: An exciting novel candidate for age-associated diseases. Exp Ther Med. 16:2175–2182. 2018.PubMed/NCBI View Article : Google Scholar
16	Szabo NJ: Dietary safety of cycloastragenol from Astragalus spp.: Subchronic toxicity and genotoxicity studies. Food Chem Toxicol. 64:322–334. 2014.PubMed/NCBI View Article : Google Scholar
17	Xiao WL, Motley TJ, Unachukwu UJ, Lau CB, Jiang B, Hong F, Leung PC, Wang QF, Livingston PO, Cassileth BR and Kennelly EJ: Chemical and genetic assessment of variability in commercial Radix Astragali (Astragalus spp.) by ion trap LC-MS and nuclear ribosomal DNA barcoding sequence analyses. J Agric Food Chem. 59:1548–1556. 2011.PubMed/NCBI View Article : Google Scholar
18	Zhang N, Wang XH, Mao SL and Zhao F: Astragaloside IV improves metabolic syndrome and endothelium dysfunction in fructose-fed rats. Molecules. 16:3896–3907. 2011.PubMed/NCBI View Article : Google Scholar
19	Wang B and Chen MZ: Astragaloside IV possesses antiarthritic effect by preventing interleukin 1beta-induced joint inflammation and cartilage damage. Arch Pharm Res. 37:793–802. 2014.PubMed/NCBI View Article : Google Scholar
20	Wang L, Gu W, Shi Y, Chen Y and Tan Y: Protective effects of astragaloside IV on IL-8-treated diaphragmatic muscle cells. Exp Ther Med. 17:519–524. 2019.PubMed/NCBI View Article : Google Scholar
21	Wang J and Guo HM: Astragaloside IV ameliorates high glucose-induced HK-2 cell apoptosis and oxidative stress by regulating the Nrf2/ARE signaling pathway. Exp Ther Med. 17:4409–4416. 2019.PubMed/NCBI View Article : Google Scholar
22	Dow CT and Harley CB: Evaluation of an oral telomerase activator for early age-related macular degeneration-a pilot study. Clin Ophthalmol. 10:243–249. 2016.PubMed/NCBI View Article : Google Scholar
23	Zheng G, Pan Z, Zhan Y, Tang Q, Zheng F, Zhou Y, Wu Y, Zhou Y, Chen D, Chen J, et al: TFEB protects nucleus pulposus cells against apoptosis and senescence via restoring autophagic flux. Osteoarthritis Cartilage. 27:347–357. 2019.PubMed/NCBI View Article : Google Scholar
24	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
25	Cawthon RM: Telomere measurement by quantitative PCR. Nucleic Acids Res. 30(e47)2002.PubMed/NCBI View Article : Google Scholar
26	Chen J, Xie JJ, Jin MY, Gu YT, Wu CC, Guo WJ, Yan YZ, Zhang ZJ, Wang JL, Zhang XL, et al: Sirt6 overexpression suppresses senescence and apoptosis of nucleus pulposus cells by inducing autophagy in a model of intervertebral disc degeneration. Cell Death Dis. 9(56)2018.PubMed/NCBI View Article : Google Scholar
27	Kletsas D: Senescent cells in the intervertebral disc: Numbers and mechanisms. Spine J. 9:677–678. 2009.PubMed/NCBI View Article : Google Scholar
28	Davalos AR, Coppe JP, Campisi J and Desprez PY: Senescent cells as a source of inflammatory factors for tumor progression. Cancer Metastasis Rev. 29:273–283. 2010.PubMed/NCBI View Article : Google Scholar
29	Yung LY, Lam WS, Ho MK, Hu Y, Ip FC, Pang H, Chin AC, Harley CB, Ip NY and Wong YH: Astragaloside IV and cycloastragenol stimulate the phosphorylation of extracellular signal-regulated protein kinase in multiple cell types. Planta Med. 78:115–121. 2012.PubMed/NCBI View Article : Google Scholar
30	Ip FC, Ng YP, An HJ, Dai Y, Pang HH, Hu YQ, Chin AC, Harley CB, Wong YH and Ip NY: Cycloastragenol is a potent telomerase activator in neuronal cells: Implications for depression management. Neurosignals. 22:52–63. 2014.PubMed/NCBI View Article : Google Scholar
31	Huang XP, Tan H, Chen BY and Deng CQ: Combination of total Astragalus extract and total Panax notoginseng saponins strengthened the protective effects on brain damage through improving energy metabolism and inhibiting apoptosis after cerebral ischemia-reperfusion in mice. Chin J Integr Med. 23:445–452. 2017.PubMed/NCBI View Article : Google Scholar
32	Zhang ZG, Wu L, Wang JL, Yang JD, Zhang J, Zhang J, Li LH, Xia Y, Yao LB, Qin HZ and Gao GD: Astragaloside IV prevents MPP(+)-induced SH-SY5Y cell death via the inhibition of Bax-mediated pathways and ROS production. Mol Cell Biochem. 364:209–216. 2012.PubMed/NCBI View Article : Google Scholar
33	Jiang C, Liu S, Cao Y and Shan H: High glucose induces autophagy through PPARγ-dependent pathway in human nucleus pulposus cells. PPAR Res. 2018(8512745)2018.PubMed/NCBI View Article : Google Scholar
34	Cheng X, Ni B, Zhang F, Hu Y and Zhao J: High glucose-induced oxidative stress mediates apoptosis and extracellular matrix metabolic imbalances possibly via p38 MAPK activation in rat nucleus pulposus cells. J Diabetes Res. 2016(3765173)2016.PubMed/NCBI View Article : Google Scholar
35	Zhou KL, Zhou YF, Wu K, Tian NF, Wu YS, Wang YL, Chen DH, Zhou B, Wang XY, Xu HZ and Zhang XL: Stimulation of autophagy promotes functional recovery in diabetic rats with spinal cord injury. Sci Rep. 5(17130)2015.PubMed/NCBI View Article : Google Scholar
36	Liang W, Ye D, Dai L, Shen Y and Xu J: Overexpression of hTERT extends replicative capacity of human nucleus pulposus cells, and protects against serum starvation-induced apoptosis and cell cycle arrest. J Cell Biochem. 113:2112–2121. 2012.PubMed/NCBI View Article : Google Scholar
37	Le Maitre CL, Freemont AJ and Hoyland JA: Accelerated cellular senescence in degenerate intervertebral discs: A possible role in the pathogenesis of intervertebral disc degeneration. Arthritis Res Ther. 9(R45)2007.PubMed/NCBI View Article : Google Scholar
38	Baltzis D, Meimeti E, Grammatikopoulou MG, Roustit M, Mavrogonatou E, Kletsas D, Efraimidou S, Manes C, Nikolouzakis TK, Tsiaoussis J, et al: Assessment of telomerase activity in leukocytes of type 2 diabetes mellitus patients having or not foot ulcer: Possible correlation with other clinical parameters. Exp Ther Med. 15:3420–3424. 2018.PubMed/NCBI View Article : Google Scholar
39	Wu J, Wang D, Ruan D, He Q, Zhang Y, Wang C, Xin H, Xu C and Liu Y: Prolonged expansion of human nucleus pulposus cells expressing human telomerase reverse transcriptase mediated by lentiviral vector. J Orthop Res. 32:159–166. 2014.PubMed/NCBI View Article : Google Scholar
40	Wu J, Wang D, Zhang C, Wang C, Zhang Y, Xin H, He Q and Ruan D: Extending the activities of human nucleus pulposus cells with recombinant adeno-associated virus vector-mediated human telomerase reverse transcriptase gene transfer. Tissue Eng Part A. 17:2407–2415. 2011.PubMed/NCBI View Article : Google Scholar
41	Illien-Junger S, Grosjean F, Laudier DM, Vlassara H, Striker GE and Iatridis JC: Combined anti-inflammatory and anti-AGE drug treatments have a protective effect on intervertebral discs in mice with diabetes. PLoS One. 8(e64302)2013.PubMed/NCBI View Article : Google Scholar
42	Antoniou J, Steffen T, Nelson F, Winterbottom N, Hollander AP, Poole RA, Aebi M and Alini M: The human lumbar intervertebral disc: Evidence for changes in the biosynthesis and denaturation of the extracellular matrix with growth, maturation, ageing, and degeneration. J Clin Invest. 98:996–1003. 1996.PubMed/NCBI View Article : Google Scholar
43	Park EY and Park JB: Dose- and time-dependent effect of high glucose concentration on viability of notochordal cells and expression of matrix degrading and fibrotic enzymes. Int Orthop. 37:1179–1186. 2013.PubMed/NCBI View Article : Google Scholar